Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 2
1992 2
1993 2
1994 2
1995 1
1996 3
1997 2
1998 1
2002 1
2003 3
2004 2
2006 1
2007 2
2008 2
2009 3
2010 4
2011 1
2012 1
2013 5
2015 2
2017 1
2019 1
2020 2
2021 1
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial).
Méndez Romero A, van der Holt B, Willemssen FEJA, de Man RA, Heijmen BJM, Habraken S, Westerveld H, van Delden OM, Klümpen HJ, Tjwa ETTL, Braam PM, Jenniskens SFM, Vanwolleghem T, Weytjens R, d'Archambeau O, de Vos-Geelen J, Buijsen J, van der Leij C, den Toom W, Sprengers D, IJzermans JNM, Moelker A. Méndez Romero A, et al. Among authors: d archambeau o. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):45-52. doi: 10.1016/j.ijrobp.2023.03.064. Epub 2023 Apr 8. Int J Radiat Oncol Biol Phys. 2023. PMID: 37037359 Free article. Clinical Trial.
Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study.
Kolligs F, Arnold D, Golfieri R, Pech M, Peynircioglu B, Pfammatter T, Ronot M, Sangro B, Schaefer N, Maleux G, Munneke G, Pereira H, Zeka B, de Jong N, Helmberger T; CIRT Principal Investigators. Kolligs F, et al. JHEP Rep. 2022 Nov 25;5(2):100633. doi: 10.1016/j.jhepr.2022.100633. eCollection 2023 Feb. JHEP Rep. 2022. PMID: 36593888 Free PMC article.
The Endovascular Treatment of Epistaxis.
Nicolay S, Van Der Zijden T, Voormolen M, d'Archambeau O, Maes J, De Belder F, Parizel PM. Nicolay S, et al. Among authors: d archambeau o. J Belg Soc Radiol. 2015 Dec 30;99(2):65-73. doi: 10.5334/jbr-btr.954. J Belg Soc Radiol. 2015. PMID: 30039110 Free PMC article.
Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study.
Maleux G, Albrecht T, Arnold D, Bargellini I, Cianni R, Helmberger T, Kolligs F, Munneke G, Peynircioglu B, Sangro B, Schaefer N, Pereira H, Zeka B, de Jong N, Bilbao JI; CIRT Principal Investigators. Maleux G, et al. Cardiovasc Intervent Radiol. 2023 Jul;46(7):852-867. doi: 10.1007/s00270-023-03391-4. Epub 2023 Mar 13. Cardiovasc Intervent Radiol. 2023. PMID: 36914788 Free PMC article.
Hepatocellular carcinoma.
Ozsarlak O, De Schepper AM, d'Archambeau O, Michielsen P, Pelckmans PA. Ozsarlak O, et al. Among authors: d archambeau o. J Belge Radiol. 1997 Dec;80(6):305. J Belge Radiol. 1997. PMID: 9479903 No abstract available.
51 results